Anhui: The reimbursement rate of outpatient expenses for infection in COVID-19 is 70%.
According to the news of Anhui Medical Insurance Bureau, on February 29th, 2022, Anhui Medical Insurance Bureau, Anhui Provincial Department of Finance and Anhui Provincial Health and Health Committee jointly issued an urgent notice on doing a good job in the outpatient treatment of novel coronavirus infection, clarifying that the medical expenses incurred by the insured in the general outpatient (emergency) treatment in the co-ordination area that meet the requirements of COVID-19 pneumonia diagnosis and treatment plan should be included in the scope of payment of the basic medical insurance co-ordination fund, and there is no deductible and reimbursement limit.
Hebei Sanhe issued a document clarifying the medical insurance reimbursement policy for COVID-19 infected people.
According to the official account of WeChat "Civilization Sanhe", the Medical Security Bureau of sanhe city, Hebei Province recently issued the "Clear Document on the Policy of Medical Insurance Reimbursement for Infected Persons in COVID-19", which clarified that the annual minimum payment standard for medical insurance outpatient service for employees is 100 yuan, and the proportion of overall fund payment is 60%, and the annual payment limit is 2,000 yuan; Over 45 years old (inclusive), the overall fund payment ratio is 60%, and the annual payment limit is 3,000 yuan; The proportion of retirees' overall fund payment is 70%, and the annual payment limit is 4000 yuan. The reimbursement policy for residents' medical insurance outpatient service as a whole is as follows: within an insured year, the insured will go to the designated medical institutions with the hospitalization qualification of urban and rural residents in the overall planning area for outpatient treatment, the annual Qifubiaozhun for outpatient service as a whole is 50 yuan, the proportion of payment from the overall planning fund is 50%, and the annual payment limit is 60 yuan. From June 5438+1 October1in 2023, the outpatient deductible line was cancelled and the annual payment limit was raised to 80 yuan/year.
Jinjiang, Fujian: Both outpatient and hospitalization can be reimbursed.
According to Jinjiang News Network, Jinjiang City, Fujian Province issued a notice on medical insurance reimbursement after COVID-19's infection: In terms of outpatient service, insured persons can enjoy general outpatient treatment when they seek medical treatment in designated primary medical institutions. The reimbursement rate in township hospitals (community health service centers) is 70%, and the maximum payment limit is 420 yuan; In the designated village-level medical institutions in the city, the reimbursement rate is 50%, and the maximum payment limit is 50 yuan (the single reimbursement limit is 10 yuan). In terms of hospitalization, medical expenses incurred in designated medical institutions in other provinces of this Municipality are reimbursed by the basic medical insurance at 80% of the reimbursement amount of this Municipality, and medical expenses incurred in designated medical institutions outside the province are reimbursed by the basic medical insurance at 60% of the reimbursement amount of this Municipality.
Shandong: Online consultation of symptoms in COVID-19 is included in medical insurance reimbursement.
According to the website of Shandong Medical Insurance Bureau, Shandong Medical Insurance Bureau and Shandong Health and Wellness Committee recently jointly issued the Notice on Doing a Good Job in Medical Insurance Services for Internet Infection in novel coronavirus, pointing out that the Internet diagnosis fee for related symptoms in COVID-19 should be included in the basic medical insurance payment scope, which is consistent with the offline reimbursement policy. The medical insurance department should promptly settle and pay the Internet plus medical expenses, strengthen intelligent audit, and promote the rational and standardized use of medical insurance funds.
Beijing: Six kinds of drugs, such as Nai Mathevet tablets and Ritonavir tablets, are temporarily included in medical insurance.
In order to cope with the new epidemic situation, with the approval of the National Medical Insurance Bureau, Beijing Medical Insurance Bureau temporarily included six drugs, such as compound paracetamol capsules, compound paracetamol and ephedrine oral liquid, paracetamol for children, Anka Huang Min capsules, clofenHuang Min tablets and ambroxol oral liquid, into the scope of medical insurance and industrial injury insurance reimbursement in Beijing, and the reimbursement ratio was implemented according to Class A drugs. It will be implemented from 12 to 18 in 2022 and will be valid until March 2023 18. In addition, in order to strengthen the treatment of patients who may develop into severe or critical illness after COVID-19's infection, recently, Naimavir Tablets/Ritonavir Tablets have also been included in the scope of medical insurance drug reimbursement in Beijing, and the reimbursement rate of community hospitals in Beijing is 90%.
Shaanxi: 234 kinds of COVID-19 drugs are temporarily included in medical insurance.
According to the "Health Shaanxi Release" news, recently, Shaanxi Provincial Medical Security Bureau, Shaanxi Provincial Health and Wellness Committee and Shaanxi Provincial State Taxation Bureau jointly issued the "Notice on Further Improving the Medical Security Work for Current Epidemic Prevention and Control". The 107 kinds of Chinese patent medicines recommended in the Notice of Shaanxi Provincial Health and Wellness Committee and Shaanxi Provincial Administration of Traditional Chinese Medicine on Printing and Distributing the Prevention and Treatment Plan for COVID-19 Infection in Shaanxi Province (Trial Fourth Edition) and the 127 kinds of medicines with strong pertinence and obvious treatment effect selected by experts organized by the US Food and Drug Administration and the Provincial Health and Wellness Committee will be temporarily included in the scope of medical insurance payment, and medical insurance will be paid until 2020.
Hubei: 36 kinds of COVID-19 drugs are temporarily included in medical insurance.
Hubei Provincial Medical Insurance Bureau released the news on February 29th, 2022. With the approval of the National Medical Insurance Bureau, 36 kinds of COVID-19 drugs, such as paracetamol for children and compound pholcodine syrup, have been temporarily included in the scope of medical insurance reimbursement in Hubei Province since February 29, 2022, and the reimbursement ratio is implemented according to Class A drugs.
Yunnan: 4 1 drugs are temporarily included in medical insurance.
On February 30th, 2022, Yunnan Medical Security Bureau announced that 4 1 drugs such as "Sangju Yinqiao Powder" in the Catalogue of Drugs for Infected Persons in COVID-19, Yunnan Province (Trial 1st Edition) were temporarily included in the scope of medical insurance payment and managed as Class A drugs, so as to further meet people's medical needs and reduce the cost burden of COVID-19 infected persons.
Guangxi: 15 kinds of COVID-19 drugs can be included in medical insurance.
According to Guangxi News Network, in order to further protect the people's demand for drugs, the Medical Security Bureau of the Autonomous Region temporarily included 15 kinds of drugs such as exogenous fever granules into the payment scope of the basic medical insurance fund of the whole region, and reimbursed them according to Class A drugs of medical insurance, which was implemented from February 22, 2022 to March 22, 2023.